You are here: Industry Insights > Cancer

News List

JCVI backs HPV jab for boys pharmatimes
July 25, 2018
The Lancet has published full results of a Phase II trial showing the benefit of Lilly’s JAK inhibitor Olumiant in the treatment of global systemic lupus erythematosus (SLE).
BI snaps up OSE’s novel checkpoint inhibitor pharmatimes
July 18, 2018
Boehringer Ingelheim and OSE Immunotherapeutics have joined forced to develop OSE-172, a novel checkpoint inhibitor antibody targeting myeloid lineage cells for the treatment of advanced solid tumours.
NICE approves treatment for rare and deadly childhood cancer pharmafile
July 17, 2018
NICE has recommended that monoclonal antibody dinutuximab beta be used in treating high-risk neuroblastoma – a rare and deadly form of cancer that mainly affects young children.
Lilly takes back cancer drug with AurKa buy pharmatimes
July 11, 2018
Eli Lilly has unveiled a deal to buy AurKa Pharma, bringing back in-house experimental fisrt-in-class cancer drug AK-01.
End-of-Life Care Depends on Doctor drugs
July 10, 2018
The amount spent on end-of-life care for cancer patients varies widely across the United States, and is largely influenced by doctor preferences, new research finds.
'Kiss of death' cancer worldpharmanews
July 05, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy.
How targeting metabolism can defeat cancer stem cells worldpharmanews
July 05, 2018
Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment.
Blood test predicts treatment response for metastatic prostate cancer europeanpharmaceuticalreview
July 03, 2018
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy…
Elderly cancer cases to increase 80% by 2035, says CRUK pharmafile
June 22, 2018
A new report from Cancer Research UK has indicated that the number of UK citizens over the age of 75 with cancer is predicted to rise by up to 80% by the year 2035.
Antiviral Treatments Reduce Cancer Risk for HIV Patients drugs
June 12, 2018
People with HIV are at increased risk for both AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) and non-AIDS-related cancers (lung and larynx cancer, melanoma and leukemia).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page